Collection: QuantaMatrix

QuantaMatrix (Seoul, Korea) develops dRAST™, the direct and rapid antimicrobial susceptibility test that reports MIC-based results from positive blood cultures in as low as 4 hours, and the QMAC-dRAST Gram-negative and Gram-positive panel kits it runs.